Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
7545 | 1356 | 29.7 | 69% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
188 | 3 | DERMATOLOGY//CONTACT DERMATITIS//PSORIASIS | 55369 |
551 | 2 | PSORIASIS//PSORIATIC ARTHRITIS//DERMATOLOGY | 14610 |
7545 | 1 | CALCIPOTRIOL//BETAMETHASONE DIPROPIONATE//TACALCITOL | 1356 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CALCIPOTRIOL | authKW | 1583376 | 9% | 60% | 118 |
2 | BETAMETHASONE DIPROPIONATE | authKW | 341954 | 2% | 56% | 27 |
3 | TACALCITOL | authKW | 320934 | 2% | 49% | 29 |
4 | PSORIASIS | authKW | 247380 | 19% | 4% | 257 |
5 | SCALP PSORIASIS | authKW | 185932 | 1% | 52% | 16 |
6 | CALCIPOTRIENE | authKW | 160830 | 1% | 71% | 10 |
7 | DERMATOLOGY | WoSSC | 112811 | 69% | 1% | 933 |
8 | TWO COMPOUND PRODUCT | authKW | 112585 | 0% | 100% | 5 |
9 | JOURNAL OF DERMATOLOGICAL TREATMENT | journal | 99559 | 6% | 6% | 77 |
10 | TAZAROTENE | authKW | 96049 | 1% | 27% | 16 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Dermatology | 112811 | 69% | 1% | 933 |
2 | Pharmacology & Pharmacy | 504 | 14% | 0% | 184 |
3 | Medicine, Research & Experimental | 256 | 6% | 0% | 85 |
4 | Medicine, General & Internal | 106 | 6% | 0% | 79 |
5 | Endocrinology & Metabolism | 69 | 4% | 0% | 55 |
6 | Primary Health Care | 56 | 1% | 0% | 10 |
7 | Allergy | 50 | 1% | 0% | 15 |
8 | CYTOLOGY & HISTOLOGY | 8 | 0% | 0% | 2 |
9 | Cell Biology | 3 | 3% | 0% | 41 |
10 | Toxicology | 2 | 1% | 0% | 16 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | DERMATOL U 905 | 90068 | 0% | 100% | 4 |
2 | PSORIASISSTUDIENZENTRUM | 67551 | 0% | 100% | 3 |
3 | BAYLOR PSORIASIS | 50662 | 0% | 75% | 3 |
4 | MANAGEMENT COMMUNITY HLTH SCI | 50662 | 0% | 75% | 3 |
5 | DERMATOL | 45557 | 33% | 0% | 444 |
6 | HUDPOLIKLIN | 45034 | 0% | 100% | 2 |
7 | BASIL GERALD FELSENSTEIN MED | 40018 | 1% | 22% | 8 |
8 | INSERM CRO2 | 37522 | 0% | 33% | 5 |
9 | MARSELISBORG | 36022 | 0% | 40% | 4 |
10 | DIS PHARMACOL | 30017 | 0% | 33% | 4 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF DERMATOLOGICAL TREATMENT | 99559 | 6% | 6% | 77 |
2 | CUTIS | 27035 | 5% | 2% | 71 |
3 | BRITISH JOURNAL OF DERMATOLOGY | 26051 | 8% | 1% | 113 |
4 | JOURNAL OF DRUGS IN DERMATOLOGY | 23731 | 3% | 3% | 42 |
5 | JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 18833 | 4% | 2% | 55 |
6 | JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 18783 | 7% | 1% | 101 |
7 | ACTA DERMATO-VENEREOLOGICA | 14769 | 4% | 1% | 54 |
8 | DERMATOLOGY | 9346 | 3% | 1% | 41 |
9 | AMERICAN JOURNAL OF CLINICAL DERMATOLOGY | 7811 | 1% | 2% | 16 |
10 | SKIN PHARMACOLOGY AND APPLIED SKIN PHYSIOLOGY | 6360 | 1% | 3% | 9 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CALCIPOTRIOL | 1583376 | 9% | 60% | 118 | Search CALCIPOTRIOL | Search CALCIPOTRIOL |
2 | BETAMETHASONE DIPROPIONATE | 341954 | 2% | 56% | 27 | Search BETAMETHASONE+DIPROPIONATE | Search BETAMETHASONE+DIPROPIONATE |
3 | TACALCITOL | 320934 | 2% | 49% | 29 | Search TACALCITOL | Search TACALCITOL |
4 | PSORIASIS | 247380 | 19% | 4% | 257 | Search PSORIASIS | Search PSORIASIS |
5 | SCALP PSORIASIS | 185932 | 1% | 52% | 16 | Search SCALP+PSORIASIS | Search SCALP+PSORIASIS |
6 | CALCIPOTRIENE | 160830 | 1% | 71% | 10 | Search CALCIPOTRIENE | Search CALCIPOTRIENE |
7 | TWO COMPOUND PRODUCT | 112585 | 0% | 100% | 5 | Search TWO+COMPOUND+PRODUCT | Search TWO+COMPOUND+PRODUCT |
8 | TAZAROTENE | 96049 | 1% | 27% | 16 | Search TAZAROTENE | Search TAZAROTENE |
9 | 1 24OH2D 3 | 90068 | 0% | 100% | 4 | Search 1+24OH2D+3 | Search 1+24OH2D+3 |
10 | COSMETIC ACCEPTABILITY | 67551 | 0% | 100% | 3 | Search COSMETIC+ACCEPTABILITY | Search COSMETIC+ACCEPTABILITY |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | MASON, AR , MASON, J , CORK, M , DOOLEY, G , HANCOCK, H , (2013) TOPICAL TREATMENTS FOR CHRONIC PLAQUE PSORIASIS.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 3. P. - | 189 | 68% | 3 |
2 | MASON, AR , MASON, J , CORK, M , DOOLEY, G , EDWARDS, G , (2009) TOPICAL TREATMENTS FOR CHRONIC PLAQUE PSORIASIS.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 2. P. - | 154 | 68% | 18 |
3 | CASTELA, E , ARCHIER, E , DEVAUX, S , GALLINI, A , ARACTINGI, S , CRIBIER, B , JULLIEN, D , AUBIN, F , BACHELEZ, H , JOLY, P , ET AL (2012) TOPICAL CORTICOSTEROIDS IN PLAQUE PSORIASIS: A SYSTEMATIC REVIEW OF EFFICACY AND TREATMENT MODALITIES.JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. VOL. 26. ISSUE . P. 36 -46 | 68 | 92% | 7 |
4 | SAMARASEKERA, EJ , SAWYER, L , WONDERLING, D , TUCKER, R , SMITH, CH , (2013) TOPICAL THERAPIES FOR THE TREATMENT OF PLAQUE PSORIASIS: SYSTEMATIC REVIEW AND NETWORK META-ANALYSES.BRITISH JOURNAL OF DERMATOLOGY. VOL. 168. ISSUE 5. P. 954-967 | 56 | 88% | 22 |
5 | HENDRIKS, AGM , KEIJSERS, RRMC , DE JONG, EMGJ , SEYGER, MMB , VAN DE KERKHOF, PCM , (2013) EFFICACY AND SAFETY OF COMBINATIONS OF FIRST-LINE TOPICAL TREATMENTS IN CHRONIC PLAQUE PSORIASIS: A SYSTEMATIC LITERATURE REVIEW.JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. VOL. 27. ISSUE 8. P. 931-951 | 57 | 85% | 4 |
6 | DEVAUX, S , CASTELA, A , ARCHIER, E , GALLINI, A , JOLY, P , MISERY, L , ARACTINGI, S , AUBIN, F , BACHELEZ, H , CRIBIER, B , ET AL (2012) TOPICAL VITAMIN D ANALOGUES ALONE OR IN ASSOCIATION WITH TOPICAL STEROIDS FOR PSORIASIS: A SYSTEMATIC REVIEW.JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. VOL. 26. ISSUE . P. 52-60 | 49 | 92% | 11 |
7 | MASON, J , MASON, AR , CORK, MJ , (2002) TOPICAL PREPARATIONS FOR THE TREATMENT OF PSORIASIS: A SYSTEMATIC REVIEW.BRITISH JOURNAL OF DERMATOLOGY. VOL. 146. ISSUE 3. P. 351 -364 | 61 | 80% | 83 |
8 | MCCORMACK, PL , (2011) CALCIPOTRIOL/BETAMETHASONE DIPROPIONATE A REVIEW OF ITS USE IN THE TREATMENT OF PSORIASIS VULGARIS OF THE TRUNK, LIMBS AND SCALP.DRUGS. VOL. 71. ISSUE 6. P. 709 -730 | 39 | 93% | 18 |
9 | MENTER, A , KORMAN, NJ , ELMETS, CA , FELDMAN, SR , GELFAND, JM , GORDON, KB , GOTTLIEB, A , KOO, JYM , LEBWOHL, M , LIM, HW , ET AL (2009) GUIDELINES OF CARE FOR THE MANAGEMENT OF PSORIASIS AND PSORIATIC ARTHRITIS SECTION 3. GUIDELINES OF CARE FOR THE MANAGEMENT AND TREATMENT OF PSORIASIS WITH TOPICAL THERAPIES.JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. VOL. 60. ISSUE 4. P. 643 -659 | 46 | 69% | 103 |
10 | VAN DE KERKHOF, PCM , KRAGBALLE, K , SEGAERT, S , LEBWOHL, M , (2011) FACTORS IMPACTING THE COMBINATION OF TOPICAL CORTICOSTEROID THERAPIES FOR PSORIASIS: PERSPECTIVES FROM THE INTERNATIONAL PSORIASIS COUNCIL.JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. VOL. 25. ISSUE 10. P. 1130-1139 | 54 | 64% | 7 |
Classes with closest relation at Level 1 |